Kwon Sarah
Manag Care. 2018 May;27(5):23-25.
Varying drug prices by indication could be an important value-based strategy in oncology, where multiple indications are becoming the rule. But will administrative costs offset any benefit? And legal and regulatory obstacles could get in the way.
根据适应症制定不同的药品价格可能是肿瘤学领域一项重要的基于价值的策略，在该领域，多种适应症正变得越来越普遍。但管理成本会抵消任何益处吗？而且法律和监管障碍可能会成为阻碍。
